RightFit Trial Directory

Leukemia clinical trials in Bethesda, MD

19 recruiting leukemia studies with a site in Bethesda, MD.

All trials in Bethesda, MD · All Leukemia trials

RecruitingPhase 1NCT06904066

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase not listedNCT01087333

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 2NCT05554393

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +174 more sites

RecruitingPhase not listedNCT05588154

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 1 / Phase 2NCT06364423

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 2NCT06317649

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Bethesda, MD · +224 more sites

RecruitingPhase not listedNCT05724121

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase not listedNCT03854318

Longitudinal Studies of Patient With FPDMM

Sponsor: National Human Genome Research Institute (NHGRI)

Bethesda, MD

RecruitingPhase 1NCT07388563

Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

RecruitingPhase 3NCT06852222

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Sponsor: Janssen Research & Development, LLC

Bethesda, MD · +58 more sites

RecruitingPhase 2NCT03986034

Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Bethesda, MD

RecruitingPhase not listedNCT00001778

Evaluation of Patients With HAM/TSP

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Bethesda, MD

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Baltimore, MD · +183 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Baltimore, MD · Bethesda, MD · +161 more sites

RecruitingPhase 1NCT05131022

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Sponsor: Nurix Therapeutics, Inc.

Bethesda, MD · +17 more sites

RecruitingPhase 1 / Phase 2NCT04068597

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Sponsor: CellCentric Ltd.

Bethesda, MD · +5 more sites

RecruitingPhase 2NCT06588478

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Sponsor: Loxo Oncology, Inc.

Bethesda, MD · +20 more sites

RecruitingPhase 3NCT06428019

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Sponsor: AbbVie

Bethesda, MD · Silver Spring, MD · +30 more sites

Not yet recruitingPhase 2NCT07524530

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

Sponsor: National Cancer Institute (NCI)

Bethesda, MD

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.